{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:12:36Z","timestamp":1790140356788,"version":"4.0.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"21","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"European Union\u2019s Horizon 2020 Research and Innovation Programme","award":["777204"],"award-info":[{"award-number":["777204"]}]},{"name":"Italian Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/eurheartj\/ehy732","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T05:10:33Z","timestamp":1542258633000},"page":"1678-1680","source":"Crossref","is-referenced-by-count":5,"title":["No heart is an island: hypertrophic cardiomyopathy, diabetes, and the test of time"],"prefix":"10.1093","volume":"40","author":[{"given":"Iacopo","family":"Olivotto","sequence":"first","affiliation":[{"name":"Cardiothoracovascular Department, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Marchionni","sequence":"additional","affiliation":[{"name":"Cardiothoracovascular Department, Careggi University Hospital, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"2022102607343801100_ehy732-B1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.critrevonc.2018.03.014","article-title":"Cardiotoxic effects of chemotherapy: a review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system","volume":"126","author":"Babiker","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"2022102607343801100_ehy732-B2","doi-asserted-by":"crossref","first-page":"e005820","DOI":"10.1161\/CIRCEP.117.005820","article-title":"Clinical course and quality of life in high risk patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators","volume":"11","author":"Maron","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2022102607343801100_ehy732-B3","doi-asserted-by":"crossref","first-page":"e007161","DOI":"10.1161\/JAHA.117.007161","article-title":"Impact of demographic features, lifestyle, and comorbidities on the clinical expression of hypertrophic cardiomyopathy","volume":"6","author":"Finocchiaro","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2022102607343801100_ehy732-B4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"2022102607343801100_ehy732-B5","doi-asserted-by":"crossref","first-page":"H873","DOI":"10.1152\/ajpheart.00682.2015","article-title":"Myocyte repolarization modulates myocardial function in aging dogs","volume":"310","author":"Sorrentino","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022102607343801100_ehy732-B6","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"key":"2022102607343801100_ehy732-B7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","article-title":"Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy","volume":"62","author":"Olivotto","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102607343801100_ehy732-B8","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/heartjnl-2016-309843","article-title":"Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK","volume":"102","author":"Sheikh","year":"2016","journal-title":"Heart"},{"key":"2022102607343801100_ehy732-B9","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jacc.2009.07.030","article-title":"High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy","volume":"54","author":"Eleid","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2022102607343801100_ehy732-B10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.117.029989","article-title":"Exercise and hypertrophic cardiomyopathy time for a change of heart","volume":"137","author":"Saberi","year":"2018","journal-title":"Circulation"},{"key":"2022102607343801100_ehy732-B11","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehy625","article-title":"The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy","volume":"40","author":"Wasserstrum","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102607343801100_ehy732-B12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/cvr\/cvy147","article-title":"Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology","volume":"114","author":"van der Velden","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2022102607343801100_ehy732-B13","doi-asserted-by":"crossref","first-page":"H150","DOI":"10.1152\/ajpheart.00737.2016","article-title":"Hyperglycemia induces defective Ca2+ homeostasis in cardiomyocytes","volume":"312","author":"Sorrentino","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022102607343801100_ehy732-B14","article-title":"Untying the knot: protein quality control in inherited cardiomyopathies","author":"Dorsch","year":"2018","journal-title":"Pfl\u00fcgers Arch"},{"key":"2022102607343801100_ehy732-B15","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jacc.2018.07.071","article-title":"The changing landscape of diabetes therapy for cardiovascular risk reduction","volume":"72","author":"Newman","year":"2018","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/21\/1678\/46635707\/eurheartj_40_21_1678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/21\/1678\/46635707\/eurheartj_40_21_1678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T07:35:11Z","timestamp":1666769711000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/21\/1678\/5193440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":15,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2018,11,20]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy732","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,1]]},"published":{"date-parts":[[2018,11,20]]}}}